← Open Payments lookup

JOHN HEAD: Open Payments

NPI 1750393690 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,249 in 356 payments from 13 companies in 2025. Trend: 2023 $3,535 · 2024 $4,849 · 2025 $7,249

Food & beverage: $7,026Education: $223
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.94$1,550
Neurocrine BioSciences, Inc.59$1,242
Otsuka America Pharmaceutical, Inc.42$924
ABBVIE INC.43$789
Alkermes, Inc.26$658
Axsome Therapeutics, Inc.22$449
Lundbeck LLC18$394
Teva Pharmaceuticals USA, Inc.4$367
Takeda Pharmaceuticals U.S.A., Inc.14$280
Indivior Inc.15$274

Products named: COBENFY, INGREZZA, REXULTI, VRAYLAR, ARISTADA, Auvelity, ABILIFY MAINTENA, TRINTELLIX.

Industry payments across MI — which companies pay providers there.